8-K current report · filed Aug 5, 2026

agilon health, inc. (AGL) 8-K Current Report: August 5, 2026

Item EX-99.1Item 2.02AGL overview

Short answer

agilon health, inc. (AGL) filed an 8-K current report with the SEC on August 5, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Press release announces agilon health financial results for Q2 and first half of fiscal 2026.

agilon health, inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Press release announces agilon health financial results for Q2 and first half of fiscal 2026
  • Results cover the three and six months ended June 30, 2026
  • Investor focus: operating performance, guidance and cash position in Exhibit 99.1

Item EX-99.1 · Exhibit EX-99.1

  • Q2 revenue rose 7% to $1.495B, while net income reached $18M versus a $104M loss, marking a major profitability inflection
  • Medical margin improved to $197M from negative $53M, supported by favorable claims development and medical cost trends
  • Adjusted EBITDA increased to $70M from negative $83M, demonstrating operating leverage despite 10% lower platform membership
  • Membership fell 10% to 549,000, reflecting market exits and profitability-focused contracting, creating a growth constraint despite stronger economics
  • Full-year guidance increased: revenue $5.775B-$5.860B, medical margin $465M-$505M, and Adjusted EBITDA $75M-$95M

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other agilon health, inc. 8-K filings

Get the next AGL 8-K as it lands

Follow AGL for push alerts, or ask the research agent what this filing means.